• About
  • Products
  • News
  • Corporate
  • Investor
    • Financial
    • Stock
  • Contact
PanGenomic Health Corp. Completes Sale to Zetta Capital Corp.

PanGenomic Health Corp. Completes Sale to Zetta Capital Corp.

by PanGenomic | Nov 9, 2021 | Uncategorized

VANCOUVER, BC, November 9, 2021 – PanGenomic Health Corp. (the “Company” or “PanGenomic Health”) is pleased to announce that its shareholders have approved the sale of all of the issued and outstanding shares of the Company to Zetta Capital Corp. (“Zetta Capital”) of...

Recent Posts

  • PanGenomic Health Subsidiary, MUJN Diagnostics, Announces the Engagement of Hemex Health to Assist in the Development of Brain Health Diagnostics System
  • PanGenomic Health Announces the Filing of a Business Acquisition Report for Mindleap Health and Provides Update on UK Listing
  • Circle Innovation to Support PanGenomic Health Subsidiary, MUJN Diagnostics, with the Development of its Decision Support System
  • PanGenomic Health Announces Availability of Women’s Hormonal Health DNA Report
  • PanGenomic Health Provides Corporate Update

Recent Comments

No comments to show.
  • Follow
  • Follow
  • Follow
  • Follow

GET IN TOUCH

info@pangenomic.com

ABOUT US

Privacy Policy

Our Story

NEWSLETTER

Contact Us

© 2023 PanGenomic Health Inc.
A public benefit company.